Novo Nordisk gatecrashes Pfizer deal with $9bn bid for Metsera
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Novo Nordisk has made a $9bn bid for Metsera, potentially disrupting a deal with Pfizer. The bid's impact on the existing agreement is unclear. A significant acquisition in the industry may be underway.